Letter to HRSA Regarding Federal Discount Prescription Drug Program


Excerpt: By its inaction, HRSA essentially turned a blind eye to entities who no longer should have been participating in the 340B program, allowing them to improperly reap the benefits of deeply discounted 340B drugs. Only last year did HRSA finally begin to ensure that participants continued to be eligible. … Maintaining the integrity of the 340B program is of the upmost importance, and we trust that you share our concerns.

To read the letter, click here.

To read a related press release, click here.

Health (113th Congress)